MEI Pharma (FRA:MMI0) 3-Year Revenue Growth Rate : 6.30% (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is MEI Pharma 3-Year Revenue Growth Rate?

MEI Pharma's Revenue per Share for the three months ended in Mar. 2024 was €0.00.

During the past 12 months, MEI Pharma's average Revenue per Share Growth Rate was 13.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 57.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of MEI Pharma was 237.10% per year. The lowest was -21.50% per year. And the median was 42.60% per year.

Competitive Comparison of MEI Pharma's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, MEI Pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MEI Pharma's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MEI Pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where MEI Pharma's 3-Year Revenue Growth Rate falls into.

MEI Pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

MEI Pharma (FRA:MMI0) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

MEI Pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of MEI Pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MEI Pharma (FRA:MMI0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (FRA:MMI0) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MEIP:USA

Address

11455 El Camino Real, Suite 250, San Diego, CA, USA, 92130

Website

https://www.meipharma.com

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

MEI Pharma (FRA:MMI0) Headlines

No Headlines